» Articles » PMID: 26057385

Comparison of High-Level Microarray Analysis Methods in the Context of Result Consistency

Overview
Journal PLoS One
Date 2015 Jun 10
PMID 26057385
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: When we were asked for help with high-level microarray data analysis (on Affymetrix HGU-133A microarray), we faced the problem of selecting an appropriate method. We wanted to select a method that would yield "the best result" (detected as many "really" differentially expressed genes (DEGs) as possible, without false positives and false negatives). However, life scientists could not help us--they use their "favorite" method without special argumentation. We also did not find any norm or recommendation. Therefore, we decided to examine it for our own purpose. We considered whether the results obtained using different methods of high-level microarray data analyses--Significant Analysis of Microarrays, Rank Products, Bland-Altman, Mann-Whitney test, T test and the Linear Models for Microarray Data--would be in agreement. Initially, we conducted a comparative analysis of the results on eight real data sets from microarray experiments (from the Array Express database). The results were surprising. On the same array set, the set of DEGs by different methods were significantly different. We also applied the methods to artificial data sets and determined some measures that allow the preparation of the overall scoring of tested methods for future recommendation.

Results: We found a very low level concordance of results from tested methods on real array sets. The number of common DEGs (detected by all six methods on fixed array sets, checked on eight array sets) ranged from 6 to 433 (22,283 total array readings). Results on artificial data sets were better than those on the real data. However, they were not fully satisfying. We scored tested methods on accuracy, recall, precision, f-measure and Matthews correlation coefficient. Based on the overall scoring, the best methods were SAM and LIMMA. We also found TT to be acceptable. The worst scoring was MW. Based on our study, we recommend: 1. Carefully taking into account the need for study when choosing a method, 2. Making high-level analysis with more than one method and then only taking the genes that are common to all methods (which seems to be reasonable) and 3. Being very careful (while summarizing facts) about sets of differentially expressed genes: different methods discover different sets of DEGs.

Citing Articles

Identification of relevant differential genes to the divergent development of pectoral muscle in ducks by transcriptomic analysis.

Li F, He Z, Lu Y, Zhou J, Cao H, Zhang X Anim Biosci. 2024; 37(8):1345-1354.

PMID: 38575126 PMC: 11222850. DOI: 10.5713/ab.23.0505.


An Artificial Intelligence Prediction Model of Insulin Sensitivity, Insulin Resistance, and Diabetes Using Genes Obtained through Differential Expression.

Gonzalez-Martin J, Torres-Mata L, Cazorla-Rivero S, Fernandez-Santana C, Gomez-Bentolila E, Clavo B Genes (Basel). 2023; 14(12).

PMID: 38136941 PMC: 10743311. DOI: 10.3390/genes14122119.


Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy.

Liu Z, Zhang N, Zhou B, Xu Y Front Pharmacol. 2022; 13:854593.

PMID: 35548365 PMC: 9083535. DOI: 10.3389/fphar.2022.854593.


Merging microarray studies to identify a common gene expression signature to several structural heart diseases.

Fajarda O, Duarte-Pereira S, M Silva R, Oliveira J BioData Min. 2020; 13:8.

PMID: 32670412 PMC: 7346458. DOI: 10.1186/s13040-020-00217-8.


Comment on "Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis".

Yang C, Zhao L, Liu X, Ma R, Xu Y J Mol Med (Berl). 2019; 97(5):737.

PMID: 30877312 DOI: 10.1007/s00109-019-01773-1.


References
1.
Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

2.
Linder R, Richards T, Wagner M . Microarray data classified by artificial neural networks. Methods Mol Biol. 2008; 382:345-72. DOI: 10.1007/978-1-59745-304-2_22. View

3.
ONeill M, Song L . Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics. 2003; 4:13. PMC: 155539. DOI: 10.1186/1471-2105-4-13. View

4.
Gautier L, Cope L, Bolstad B, Irizarry R . affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004; 20(3):307-15. DOI: 10.1093/bioinformatics/btg405. View

5.
Larsson O, Wahlestedt C, Timmons J . Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics. 2005; 6:129. PMC: 1173086. DOI: 10.1186/1471-2105-6-129. View